| Dr Elizabeth Ann Tacl, MD | |
|
1200 6th Ave N, Saint Cloud, MN 56303-2736 | |
| (320) 252-5131 | |
| Not Available |
| Full Name | Dr Elizabeth Ann Tacl |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 9 Years |
| Location | 1200 6th Ave N, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093194706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 69959 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Cloud Hospital | Saint cloud, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centracare Clinic | 2466363395 | 632 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20031231000690 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Long Prairie |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164471678 PECOS PAC ID: 3870524598 Enrollment ID: O20050823000460 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20060504000839 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Long Prairie |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1164471678 PECOS PAC ID: 3870524598 Enrollment ID: O20061104000579 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | St Cloud Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269798 PECOS PAC ID: 4880594779 Enrollment ID: O20110221000134 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Sauk Centre |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578813762 PECOS PAC ID: 4981857216 Enrollment ID: O20130116000380 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275872772 PECOS PAC ID: 3870739410 Enrollment ID: O20130426000215 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558600874 PECOS PAC ID: 3870739410 Enrollment ID: O20130515000683 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health-paynesville Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205269941 PECOS PAC ID: 1153555719 Enrollment ID: O20131108000012 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health System - Sauk Centre |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740553932 PECOS PAC ID: 4981857216 Enrollment ID: O20140523001292 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Entity Name | Centracare Health-paynesville Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629402516 PECOS PAC ID: 1153555719 Enrollment ID: O20140909002390 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Ann Tacl, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Elizabeth Ann Tacl, MD 1200 6th Ave N, Saint Cloud, MN 56303-2736 Ph: (320) 252-5131 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
How robots can improve care for people in aged care will be the focus this week (25 Nov) at Griffith University's Social Robotics and Assistive Technology Laboratory opening.
Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC's dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
› Verified 3 days ago
Mark Engelsgjerd, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 251 County Rd 120, Saint Cloud, MN 56303 Phone: 320-202-8949 Fax: 320-202-0756 | |
Dr. Liana M. Lugo, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3701 12th St N, Suite 100, Saint Cloud, MN 56303 Phone: 320-253-7257 | |
Arnes Huskic, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 4801 Veterans Dr, Saint Cloud, MN 56303 Phone: 320-252-1670 | |
James L Jost, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Robert Shapiro, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 251 County Rd 120, Saint Cloud, MN 56303 Phone: 320-202-8949 Fax: 320-202-0756 | |
Stephen J Sahlstrom, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |